BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With clinical momentum from Eli Lilly's lipidated brain shuttl
 e siRNAs\, Alnylam Pharmaceuticals' ALN-APP siRNA\, Wave's Phase 1b/2a po
 sitive SELECT-HD data\, 170+ biotech and 30+ pharma active in the field\,
  and a surge of novel approaches\, the oligonucleotide field shows no sig
 ns of slowing down.\n\nThe 5th Oligonucleotides for CNS Summit unites a s
 elect group of industry-leading biologists\, chemists\, C-level executive
 s\, platform tech experts\, DMPK and clinical pharmacologists\, all tackl
 ing the unique challenges of CNS delivered ASOs\, siRNAs\, miRNAs and saR
 NAs.\n\nThis August\, hear from Alnylam Pharmaceuticals\, Denali Therapeu
 tics\, Genentech\, FDA\, Novo Nordisk\, Regeneron\, Servier\, Stoke Thera
 peutics\, Ultragenyx Pharmaceutical and more\, to redefine the landscape 
 of oligonucleotide research.\n\nDate and Time: Wednesday\, 27 August 2025
  at 08:30 to Friday\, 29 August 2025 at 16:05\n
DTEND:20250829T160500
DTSTAMP:20260512T214305Z
DTSTART:20250827T083000
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, Massach
 usetts\, 02116\,
SEQUENCE:0
SUMMARY:With clinical momentum from Eli Lilly's lipidated brain shuttle si
 RNAs\, Alnylam Pharmaceuticals' ALN-APP siRNA\, Wave's Phase 1b/2a positi
 ve SELECT-...
UID:4410fc80-3bb4-4537-a51f-c3f2bb9fd544
END:VEVENT
END:VCALENDAR